Basic Info
  • Factory Location: Lianyungang

    Main Sales Markets: Asia

  • Sample Provided: no

    China GMP

    Form: tablet

    Strength: 20mg, 50mg

    Indication: newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase; chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate.

Send your message to this supplier
  • From:
  • To:
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
  • Cc:
  • Verification Code:
  • Message:

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now